KBP Biosciences Lands $76M, an Ex-GlaxoSmithKline Exec as Its New CEO and a HQ Move to Philly Post author:Sam Post published:January 4, 2018 Post category:BioPharma The financing was co-led by Advantech Capital and SDIC Venture Capital. Source: BioSpace You Might Also Like 3 Biotech Stocks That Exploded in 2017 December 4, 2017 4 Biotechs Facing Do-or-Die Catalysts in December December 5, 2017 Trading In Novo Nordisk A/S Shares By Board Members, Executives And Associated Persons On 8 May 2017 May 8, 2017
Trading In Novo Nordisk A/S Shares By Board Members, Executives And Associated Persons On 8 May 2017 May 8, 2017
